Celebrating 10 Years of Residency Program Excellence

2023 is a year of celebration at Navitus. Not only is it the 20th anniversary of our founding, but 2023 also marks 10 years of Navitus' residency...

Read More
Employee Spotlight

Humira Biosimilars – Update for October Formularies

Our recent August Pharmacy and Therapeutics (P&T) Committee meeting reviewed the release of various Humira® biosimilars. Staying true to our...

Read More
Industry News, Specialty

Legal Ease: A Navitus Government Affairs Update

In an ever-changing legislative landscape, we want to help our clients and partners stay informed of the latest happenings and how proposed policies...

Read More
Industry News

Humira Biosimilars – Summer of Blockbuster Releases for Navitus to Review

This summer has seen a continuation of the long-awaited market entry of Humira® (adalimumab) biosimilars. As of July 1, nine additional biosimilars...

Read More
Industry News, Specialty

Transforming Access to Pharmacy Benefits: 2022 Drug Trend Report

We are pleased to share our 2022 Drug Trend Report with you. This year's report highlights our success in managing pharmacy benefit costs for our...

Read More
Industry News
Q&A with George Hepburn, Chief Financial Officer

Employee Spotlight: George Hepburn

We had the pleasure of connecting with our new Chief Financial Officer, George Hepburn, to discuss what excites him about his new role, what inspires...

Read More
Employee Spotlight
Q&A with Ken Goodnight, Chief Transformation and Digital Officer

Employee Spotlight: Ken Goodnight

We recently sat down with Ken Goodnight to discuss his key priorities as Chief Transformation & Digital Officer and to learn about his professional...

Read More
Employee Spotlight

Humira Biosimilars Enter the Marketplace – Update on Navitus’ Review

The market entry of biosimilars to Humira® (adalimumab) is long-awaited. These products have the potential to improve affordability in the near- and...

Read More
Industry News, Specialty

Five Forecasts and Takeaways for Plan Sponsors in 2023

As we enter 2023, David Fields is sharing his top forecasts and takeaways for plan sponsors and the PBM industry.

Read More
Industry News, Specialty

Employee Spotlight: Shelly McAdoo

As we continue our employee spotlight series, we are excited to highlight Shelly McAdoo, Navitus’ new Diversity, Equity and Inclusion (DEI) Senior...

Read More
Employee Spotlight
Inflation Reduction Act of 2022

Understanding the Inflation Reduction Act of 2022

Navitus’ Vice President of Government Relations, Robyn Crosson, shares her insight into the Inflation Reduction Act and how it will impact our...

Read More
Industry News

Key Findings: 2021 Navitus Drug Trend Report

This week we provide an overview of our 2021 drug trend and client savings with insights for 2022 and beyond.

Read More
Industry News

Recent Posts